243 related articles for article (PubMed ID: 23300679)
1. On the interplay of telomeres, nevi and the risk of melanoma.
Bodelon C; Pfeiffer RM; Bollati V; Debbache J; Calista D; Ghiorzo P; Fargnoli MC; Bianchi-Scarra G; Peris K; Hoxha M; Hutchinson A; Burdette L; Burke L; Fang S; Tucker MA; Goldstein AM; Lee JE; Wei Q; Savage SA; Yang XR; Amos C; Landi MT
PLoS One; 2012; 7(12):e52466. PubMed ID: 23300679
[TBL] [Abstract][Full Text] [Related]
2. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
Chaudru V; Chompret A; Bressac-de Paillerets B; Spatz A; Avril MF; Demenais F
J Natl Cancer Inst; 2004 May; 96(10):785-95. PubMed ID: 15150307
[TBL] [Abstract][Full Text] [Related]
3. Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom.
Newton-Bishop JA; Chang YM; Iles MM; Taylor JC; Bakker B; Chan M; Leake S; Karpavicius B; Haynes S; Fitzgibbon E; Elliott F; Kanetsky PA; Harland M; Barrett JH; Bishop DT
Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2043-54. PubMed ID: 20647408
[TBL] [Abstract][Full Text] [Related]
4. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
[TBL] [Abstract][Full Text] [Related]
5. No association between telomere length-related loci and number of cutaneous nevi.
Li X; Liang G; Du M; De Vivo I; Nan H
Oncotarget; 2016 Dec; 7(50):82396-82399. PubMed ID: 27637081
[TBL] [Abstract][Full Text] [Related]
6. [The number and distribution of nevus cell nevi in patients with malignant melanoma].
Welkovich B; Landthaler M; Schmoeckel C; Braun-Falco O
Hautarzt; 1989 Oct; 40(10):630-5. PubMed ID: 2613517
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families.
Liang X; Pfeiffer RM; Li WQ; Brossard M; Burke LS; Wheeler W; Calista D; Fargnoli MC; Ghiorzo P; Peris K; Bianchi-Scarra G; Chaudru V; Zelenika D; Maeder D; Burdette L; Yeager M; Chanock S; Landi MT; Demenais F; Tucker MA; Goldstein AM; Yang XR
J Invest Dermatol; 2014 Feb; 134(2):481-487. PubMed ID: 23892592
[TBL] [Abstract][Full Text] [Related]
8. Dysplastic nevi are a risk factor for uveal melanoma.
Hammer H; Oláh J; Tóth-Molnár E
Eur J Ophthalmol; 1996; 6(4):472-4. PubMed ID: 8997595
[TBL] [Abstract][Full Text] [Related]
9. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
10. Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
Burke LS; Hyland PL; Pfeiffer RM; Prescott J; Wheeler W; Mirabello L; Savage SA; Burdette L; Yeager M; Chanock S; De Vivo I; Tucker MA; Goldstein AM; Yang XR
PLoS One; 2013; 8(8):e71121. PubMed ID: 23990928
[TBL] [Abstract][Full Text] [Related]
11. A distinctive melanocytic lesion associated with melanoma-prone dysplastic naevus syndrome: the hybrid naevus.
Schubert C; Parwaresch R; Rudolph P
Virchows Arch; 2001 Feb; 438(2):166-72. PubMed ID: 11253119
[TBL] [Abstract][Full Text] [Related]
12. [Do Finnish melanoma patients have dysplastic nevi?].
Lapatto O; Kariniemi AL; Asko-Seljavaara S
Duodecim; 1992; 108(11):1054-8. PubMed ID: 1366023
[No Abstract] [Full Text] [Related]
13. Risk of melanoma and other cancers in melanoma-prone families.
Tucker MA; Fraser MC; Goldstein AM; Elder DE; Guerry D; Organic SM
J Invest Dermatol; 1993 Mar; 100(3):350S-355S. PubMed ID: 8440923
[TBL] [Abstract][Full Text] [Related]
14. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
Goldstein AM; Martinez M; Tucker MA; Demenais F
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):889-94. PubMed ID: 11008905
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of melanoma in "dysplastic" nevus spilus: report of case and analysis by flow cytometry.
Kurban RS; Preffer FI; Sober AJ; Mihm MC; Barnhill RL
J Cutan Pathol; 1992 Oct; 19(5):423-8. PubMed ID: 1474193
[TBL] [Abstract][Full Text] [Related]
16. Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families.
Novakovic B; Clark WH; Fears TR; Fraser MC; Tucker MA
J Am Acad Dermatol; 1995 Oct; 33(4):631-6. PubMed ID: 7673498
[TBL] [Abstract][Full Text] [Related]
17. Dysplastic nevi, cutaneous melanoma, and other skin neoplasms in patients with myotonic dystrophy type 1: a cross-sectional study.
Zampetti A; Silvestri G; Manco S; Khamis K; Masciullo M; Bianchi ML; Damiani A; Santoro M; Linder D; Bewley A; Feliciani C
J Am Acad Dermatol; 2015 Jan; 72(1):85-91. PubMed ID: 25440959
[TBL] [Abstract][Full Text] [Related]
18. Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk.
Llorca-Cardeñosa MJ; Peña-Chilet M; Mayor M; Gomez-Fernandez C; Casado B; Martin-Gonzalez M; Carretero G; Lluch A; Martinez-Cadenas C; Ibarrola-Villava M; Ribas G
Eur J Cancer; 2014 Dec; 50(18):3168-77. PubMed ID: 25457634
[TBL] [Abstract][Full Text] [Related]
19. A relation between childhood sun exposure and dysplastic nevus syndrome among patients with nonfamilial melanoma.
Titus-Ernstoff L; Ernstoff MS; Duray PH; Barnhill RL; Holubkov R; Kirkwood JM
Epidemiology; 1991 May; 2(3):210-4. PubMed ID: 2054404
[TBL] [Abstract][Full Text] [Related]
20. Dysplastic (atypical) nevi: significance and management.
Lober CW
South Med J; 1992 Sep; 85(9):870-7. PubMed ID: 1523445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]